Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial

Saved in:
Bibliographic Details
Published inHaemophilia : the official journal of the World Federation of Hemophilia Vol. 29; no. 1; pp. 404 - 407
Main Authors Sidonio, Robert F., Casiano, Sandra, Falk, Aletta, Altincatal, Arman, Katragadda, Suresh, Santagostino, Elena, Windyga, Jerzy
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.01.2023
Subjects
clinical study
Coagulation factors
factor IX
Factor IX - pharmacokinetics
Factor IX - therapeutic use
factor IX Fc fusion protein
Fc receptors
Fusion protein
haemophilia B
Hemophilia B - drug therapy
Humans
Immunoglobulin Fc Fragments - therapeutic use
Pharmacokinetics
Recombinant Fusion Proteins - pharmacokinetics
Recombinant Fusion Proteins - therapeutic use
clinical study
pharmacokinetics
factor IX
haemophilia B
factor IX Fc fusion protein
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Correspondence-3
content type line 23
ISSN:1351-8216
1365-2516
1365-2516
DOI:10.1111/hae.14727